COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,186,389 | +9.3% | 97,825 | +5.1% | 0.00% | 0.0% |
| Q2 2023 | $2,000,397 | +3.9% | 93,085 | +16.0% | 0.00% | 0.0% |
| Q1 2023 | $1,925,605 | +2.1% | 80,267 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $1,886,346 | +46.5% | 81,308 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $1,288,000 | -9.4% | 80,409 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $1,421,000 | -13.9% | 80,198 | -1.0% | 0.00% | 0.0% |
| Q1 2022 | $1,650,000 | +8.4% | 81,034 | -0.5% | 0.00% | – |
| Q4 2021 | $1,522,000 | -4.5% | 81,462 | +0.9% | 0.00% | -100.0% |
| Q3 2021 | $1,594,000 | -8.7% | 80,728 | +9.4% | 0.00% | 0.0% |
| Q2 2021 | $1,745,000 | -24.4% | 73,817 | -24.1% | 0.00% | 0.0% |
| Q1 2021 | $2,307,000 | +1888.8% | 97,316 | +1573.2% | 0.00% | – |
| Q4 2020 | $116,000 | -5.7% | 5,816 | -0.9% | 0.00% | – |
| Q3 2020 | $123,000 | -5.4% | 5,867 | -20.9% | 0.00% | – |
| Q2 2020 | $130,000 | +39.8% | 7,418 | +30.1% | 0.00% | – |
| Q1 2020 | $93,000 | -36.3% | 5,702 | -19.9% | 0.00% | – |
| Q4 2019 | $146,000 | +114.7% | 7,123 | +21.2% | 0.00% | – |
| Q3 2019 | $68,000 | -12.8% | 5,879 | 0.0% | 0.00% | – |
| Q2 2019 | $78,000 | -2.5% | 5,879 | +12.1% | 0.00% | – |
| Q1 2019 | $80,000 | -12.1% | 5,245 | 0.0% | 0.00% | – |
| Q4 2018 | $91,000 | +28.2% | 5,245 | +7.7% | 0.00% | – |
| Q3 2018 | $71,000 | -38.8% | 4,871 | 0.0% | 0.00% | – |
| Q2 2018 | $116,000 | +3.6% | 4,871 | +11.2% | 0.00% | – |
| Q1 2018 | $112,000 | -3.4% | 4,379 | -29.9% | 0.00% | – |
| Q4 2017 | $116,000 | +96.6% | 6,245 | +11.4% | 0.00% | – |
| Q3 2017 | $59,000 | -14.5% | 5,605 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +43.8% | 5,605 | +20.4% | 0.00% | – |
| Q1 2017 | $48,000 | -36.0% | 4,655 | -1.9% | 0.00% | – |
| Q4 2016 | $75,000 | +74.4% | 4,744 | +96.4% | 0.00% | – |
| Q3 2016 | $43,000 | +53.6% | 2,416 | 0.0% | 0.00% | – |
| Q2 2016 | $28,000 | – | 2,416 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $48,689,000 | 2.30% |
| Camber Capital Management LP | 1,050,000 | $19,614,000 | 0.67% |
| OneAscent Wealth Management LLC | 14,131 | $264,000 | 0.66% |
| Eventide Asset Management | 2,629,593 | $49,121,000 | 0.63% |
| CLARK ESTATES INC/NY | 183,800 | $3,433,000 | 0.50% |
| Values First Advisors, Inc. | 42,312 | $790,000 | 0.47% |
| RICE HALL JAMES & ASSOCIATES, LLC | 704,201 | $13,154,000 | 0.47% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 650,398 | $12,149,000 | 0.43% |
| OneAscent Financial Services LLC | 11,774 | $220,000 | 0.42% |
| Factorial Partners, LLC | 33,300 | $622,000 | 0.41% |